Can the Lung Cancer Pie Be Divided into Angiogenic Slices?

por Cascone, Tina, Heymach, John V.
Publicado en Clin Cancer Res (2015)

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer

por Sepesi, Boris, Cascone, Tina, Chun, Stephen G., Altan, Mehmet, Le, Xiuning
Publicado en Surg Oncol Clin N Am (2020)

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer

por Pradhan, Monika, Chocry, Mathieu, Gibbons, Don L., Sepesi, Boris, Cascone, Tina
Publicado en Transl Lung Cancer Res (2021)

Targeted Therapies for Lung Cancer: Clinical Experience and Novel Agents

por Larsen, Jill E., Cascone, Tina, Gerber, David E., Heymach, John V., Minna, John D.
Publicado 2011

Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy

por Bhardwaj, Vikas, Cascone, Tina, Cortez, M Angelica, Amini, Arya, Evans, Jaden, Komaki, Ritusko U, Heymach, John V, Welsh, James W
Publicado 2013

Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer

por Byers, Lauren Averett, Sen, Banibrata, Saigal, Babita, Diao, Lixia, Wang, Jing, Nanjundan, Meera, Cascone, Tina, Mills, Gordon B., Heymach, John V., Johnson, Faye M.
Publicado 2009

Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy

por Mehran, Reza, Nilsson, Monique, Khajavi, Mehrdad, Du, Zhiqiang, Cascone, Tina, Wu, Hua Kang, Cortes, Andrea, Xu, Li, Zurita, Amado, Schier, Robert, Riedel, Bernhard, El-Zein, Randa, Heymach, John V.
Publicado 2014

Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged Non-Small Cell Lung Cancer with brain metastases

por Subbiah, Vivek, Berry, Jenny, Roxas, Michael, Guha-Thakurta, Nandita, Subbiah, Ishwaria Mohan, Ali, Siraj M., McMahon, Caitlin, Miller, Vincent, Cascone, Tina, Pai, Shobha, Tang, Zhenya, Heymach, John V.
Publicado en Lung Cancer (2015)

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

por Cascone, Tina, Gold, Kathryn A., Swisher, Stephen G., Liu, Diane D., Fossella, Frank V., Sepesi, Boris, Pataer, Apar, Weissferdt, Annikka, Kalhor, Neda, Vaporciyan, Ara, Hofstetter, Wayne L., Wistuba, Ignacio I., Heymach, John V., Kim, Edward S., William, William N.
Publicado en Ann Thorac Surg (2017)

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma

por Cascone, Tina, Herynk, Matthew H., Xu, Li, Du, Zhiqiang, Kadara, Humam, Nilsson, Monique B., Oborn, Carol J., Park, Yun-Yong, Erez, Baruch, Jacoby, Jörg J., Lee, Ju-Seog, Lin, Heather Y., Ciardiello, Fortunato, Herbst, Roy S., Langley, Robert R., Heymach, John V.
Publicado 2011

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

por Weissferdt, Annikka, Pataer, Apar, Vaporciyan, Ara A., Correa, Arlene M., Sepesi, Boris, Moran, Cesar A., Wistuba, Ignacio I., Roth, Jack A., Shewale, Jitesh Baban, Heymach, John V., Kalhor, Neda, Cascone, Tina, Hofstetter, Wayne L., Lee, J. Jack, Swisher, Stephen G.
Publicado en Clin Lung Cancer (2020)

Lymphovascular Invasion Is Associated with Mutational Burden and PD-L1 in Resected Lung Cancer

por Mitchell, Kyle G., Negrao, Marcelo V., Parra, Edwin R., Li, Jun, Zhang, Jianhua, Dejima, Hitoshi, Vaporciyan, Ara A., Swisher, Stephen G., Weissferdt, Annikka, Antonoff, Mara B., Cascone, Tina, Roarty, Emily, Wistuba, Ignacio I., Heymach, John V., Gibbons, Don L., Zhang, Jianjun, Sepesi, Boris
Publicado en Ann Thorac Surg (2019)

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling

por Wagner, Klaus W., Alam, Hunain, Dhar, Shilpa S., Giri, Uma, Li, Na, Wei, Yongkun, Giri, Dipak, Cascone, Tina, Kim, Jae-Hwan, Ye, Yuanqing, Multani, Asha S., Chan, Chia-Hsin, Erez, Baruch, Saigal, Babita, Chung, Jimyung, Lin, Hui-Kuan, Wu, Xifeng, Hung, Mien-Chie, Heymach, John V., Lee, Min Gyu
Publicado 2013

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

por Naumov, George N., Nilsson, Monique B., Cascone, Tina, Briggs, Alexandra, Straume, Oddbjorn, Akslen, Lars A., Lifshits, Eugene, Byers, Lauren Averett, Xu, Li, Wu, Hua-kang, Jänne, Pasi, Kobayashi, Susumu, Halmos, Balazs, Tenen, Daniel, Tang, Xi M., Engelman, Jeffrey, Yeap, Beow, Folkman, Judah, Johnson, Bruce E., Heymach, John V.
Publicado 2009

A β3 integrin-KRAS-RalB complex drives tumor stemness and resistance to EGFR inhibition

por Seguin, Laetitia, Kato, Shumei, Franovic, Aleksandra, Camargo, M. Fernanda, Lesperance, Jacqueline, Elliott, Kathryn C., Yebra, Mayra, Mielgo, Ainhoa, Lowy, Andrew M., Husain, Hatim, Cascone, Tina, Diao, Lixia, Wang, Jing, Wistuba, Ignacio I., Heymach, John V., Lippman, Scott M., Desgrosellier, Jay S., Anand, Sudarshan, Weis, Sara M., Cheresh, David A.
Publicado 2014

Altered regulation of HIF-1α in naïve- and drug-resistant EGFR mutant NSCLC: implications for a VEGF-dependent phenotype

por Nilsson, Monique B., Robichaux, Jacqulyne, Herynk, Matthew H., Cascone, Tina, Le, Xuining, Elamin, Yasir, Patel, Sonia, Zhang, Fahao, Xu, Li, Hu, Limei, Diao, Lixia, Shen, Li, He, Junqin, Yu, Xiaoxing, Nikolinakos, Petros, Saintigny, Pierre, Fang, Bingliang, Girard, Luc, Wang, Jing, Minna, John D., Wistuba, Ignacio I., Heymach, John V.
Publicado en J Thorac Oncol (2020)

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

por Parra, Edwin R., Villalobos, Pamela, Behrens, Carmen, Jiang, Mei, Pataer, Apar, Swisher, Stephen G., William, William N., Zhang, Jiexin, Lee, Jack, Cascone, Tina, Heymach, John V., Forget, Marie-Andrée, Haymaker, Cara, Bernatchez, Chantale, Kalhor, Neda, Weissferdt, Annikka, Moran, Cesar, Zhang, Jianjun, Vaporciyan, Ara, Gibbons, Don L., Sepesi, Boris, Wistuba, Ignacio I.
Publicado en J Immunother Cancer (2018)

Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care

por Simon, George, DiNardo, Courtney D., Takahashi, Koichi, Cascone, Tina, Powers, Cynthia, Stevens, Rick, Allen, Joshua, Antonoff, Mara B., Gomez, Daniel, Keane, Pat, Suarez Saiz, Fernando, Nguyen, Quynh, Roarty, Emily, Pierce, Sherry, Zhang, Jianjun, Hardeman Barnhill, Emily, Lakhani, Kate, Shaw, Kenna, Smith, Brett, Swisher, Stephen, High, Rob, Futreal, P. Andrew, Heymach, John, Chin, Lynda
Publicado en Oncologist (2018)

Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively i...

por Mitchell, Kyle G, Diao, Lixia, Karpinets, Tatiana, Negrao, Marcelo V, Tran, Hai T, Parra, Edwin R, Corsini, Erin M, Reuben, Alexandre, Federico, Lorenzo, Bernatchez, Chantale, Dejima, Hitoshi, Francisco-Cruz, Alejandro, Wang, Jing, Antonoff, Mara B, Vaporciyan, Ara A, Swisher, Stephen G, Cascone, Tina, Wistuba, Ignacio I, Heymach, John V, Gibbons, Don L, Zhang, Jianjun, Haymaker, Cara L, Sepesi, Boris
Publicado en J Immunother Cancer (2020)

The HGF/c-MET pathway is a driver and biomarker of VEGFR-inhibitor resistance and vascular remodeling in non-small cell lung cancer

por Cascone, Tina, Xu, Li, Lin, Heather Y., Liu, Wenbin, Tran, Hai T., Liu, Yuan, Howells, Kathryn, Haddad, Vincent, Hanrahan, Emer, Nilsson, Monique B., Cortez, Maria A., Giri, Uma, Kadara, Humam, Saigal, Babita, Park, Yun-Yong, Peng, Weiyi, Lee, Ju-Seog, Ryan, Anderson J., Jüergensmeier, Juliane M., Herbst, Roy S., Wang, Jing, Langley, Robert R., Wistuba, Ignacio I., Lee, Jack J., Heymach, John V.
Publicado en Clin Cancer Res (2017)